Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$72.5 - $100.68 $441,670 - $613,342
-6,092 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$90.24 - $124.05 $43,766 - $60,164
485 Added 8.65%
6,092 $581,000
Q2 2021

Aug 12, 2021

BUY
$93.66 - $139.27 $525,151 - $780,886
5,607 New
5,607 $697,000
Q4 2018

Feb 08, 2019

SELL
$56.04 - $82.66 $19,614 - $28,931
-350 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$48.29 - $80.6 $14,245 - $23,777
295 Added 536.36%
350 $28,000
Q3 2018

Nov 07, 2018

SELL
$48.29 - $80.6 $26,076 - $43,524
-540 Reduced 90.76%
55 $25,000
Q2 2018

Aug 13, 2018

BUY
$37.84 - $69.96 $22,514 - $41,626
595 New
595 $37,000
Q1 2018

May 04, 2018

SELL
$39.82 - $57.53 $14,972 - $21,631
-376 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$46.49 - $60.51 $7,531 - $9,802
162 Added 75.7%
376 $19,000
Q3 2017

Nov 09, 2017

BUY
$37.05 - $47.12 $7,928 - $10,083
214
214 $10,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.